Infectious Agents and Cancer (Oct 2012)

HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies

  • Giorgi Rossi Paolo,
  • Sideri Mario,
  • Carozzi Francesca,
  • Vocaturo Amina,
  • Buonaguro Franco,
  • Tornesello Maria,
  • Burroni Elena,
  • Mariani Luciano,
  • Boveri Sara,
  • Zaffina Leandra,
  • Chini Francesco

DOI
https://doi.org/10.1186/1750-9378-7-26
Journal volume & issue
Vol. 7, no. 1
p. 26

Abstract

Read online

Abstract Objective The aim of this study is to describe the prevalence of HPV types in invasive cervical cancers in Italy from 1996 to 2008. Methods A pooled analysis of the three largest case series typed to date was performed. HPV typing was performed on paraffin-embedded slices. Molecular analyses were performed in four laboratories. Multivariate analyses were performed to test the associations between calendar time, age, and geographical area and the proportion of types 16/18. Results Out of 574 cancers, 24 (4.2%) were HPV negative. HPV 16 and 18 were responsible for 74.4% (378/508) and 80.3% (49/61) of the squamous cancers and adenocarcinomas, respectively. Other frequent types were 31 (9.5%), 45 (6.4%), and 58 (3.3%) for squamous cancers and 45 (13.3%), 31, 35, and 58 (5.0%) for adenocarcinomas. The proportion of HPV 16 and/or 18 decreased with age (p-value for trend Conclusions The impact of HPV 16/18 vaccine on cervical cancer will be greater for early onset cancers. In vaccinated women, screening could be started at an older age without reducing protection.